RADx-UP CDCC SAY YES COVID Test Study
RADx-UP CDCC 同意 COVID 测试研究
基本信息
- 批准号:10366485
- 负责人:
- 金额:$ 765.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-27 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressAdmission activityAffectAttitudeBehaviorBehavioralBioinformaticsBiometryCOVID testCOVID-19 pandemicCenters for Disease Control and Prevention (U.S.)Cessation of lifeClinical ResearchClinical TrialsCommunitiesConsentContact TracingCountyDataData CollectionDiseaseEpidemiologyEvaluationFutureGoalsHealthHealth Knowledge, Attitudes, PracticeHealth behaviorHigh PrevalenceHomeHospitalizationHospitalsHumanIndividualInfectionInfrastructureInterventionKnowledgeLeadLeadershipMeasuresMorbidity - disease rateNorth CarolinaOutcomeParticipantPopulationPopulation ProgramsPreventionPublic HealthQuarantineRADxResearchResearch InstituteSARS-CoV-2 infectionSARS-CoV-2 transmissionScienceSiteSocial InteractionTarget PopulationsTestingTimeUnderserved PopulationUnited States National Institutes of HealthUniversitiesVaccinesViralVirusVisioncohortcommunity engagementcoronavirus diseasecostexperiencehealth care service utilizationhealth equityhome testindexingmarginalized populationnovelnovel strategiesoperationpandemic diseaseprimary outcomeprogramspublic health interventionrapid testresearch studyscreeningsecondary outcomeskillssmartphone Applicationtransmission processuptakewastewater surveillance
项目摘要
Over 4 million people have been infected with the SARS-CoV-2 virus and more than 460,000 have died. Novel
mitigation strategies and community level public health interventions are critical to stop the spread of this virus.
The goal of frequent home testing is to identify SARS-CoV-2 index cases early, trigger isolation and
quarantining precautions, and ultimately decrease community transmission. We will evaluate a public health
intervention combining frequent at-home testing with broad community engagement strategies, to reduce
SARS-CoV-2 virus community transmission and conduct a study in a cohort of the population to understand
the human behavior factors affecting viral testing. This approach will allow us to answer questions regarding
community transmission for the SARS-CoV-2 pandemic as well as additional questions relevant for
implementation of public health interventions in future pandemics. We will partner with the CDC to evaluate
community dissemination of 2 million rapid tests in a public health intervention of rapid, twice weekly at home
testing in up to 3 communities 1) with high prevalence of disease 2) that have reliable publicly available
outcome data and 3) that overlap with current RADx-UP sites to leverage the robust infrastructure of the CDCC
and support community engagement through the testing projects. To evaluate whether frequent rapid at-home
testing strategy decreases community transmission of and morbidity from SARS-CoV-2 over a 5-week period,
our primary outcomes include measures of community transmission (hospital capacity/health care utilization,
composite measure of community transmission, wastewater surveillance), and morbidity (hospitalizations,
covid-like illness). Our secondary outcomes include (community mobility, PCR turn-around time, ICU
admissions, contact tracing episodes, and percent test positivity). In addition, we will conduct a substudy to
assess behavioral determinants of testing (social interaction, health behaviors, healthcare utilization,
prevention knowledge and vaccine attitudes) using a smart phone application with consenting participants in
the public health intervention.
超过400万人感染了SARS-CoV-2病毒,超过46万人死亡。小说
缓解战略和社区一级的公共卫生干预措施对于阻止这一病毒的传播至关重要。
频繁进行家庭检测的目的是及早发现SARS-CoV-2指数病例,触发隔离,
加强预防措施,最终减少社区传播。我们将评估一个公共卫生
将频繁的家庭检测与广泛的社区参与战略相结合,
SARS-CoV-2病毒的社区传播并在人群中进行队列研究以了解
影响病毒检测的人类行为因素。这种方法将使我们能够回答有关
SARS-CoV-2大流行的社区传播以及与以下方面相关的其他问题
在未来的大流行病中实施公共卫生干预措施。我们将与疾控中心合作,
在社区分发200万个快速检测,每周两次在家中进行快速公共卫生干预
在最多3个社区进行检测,1)疾病流行率高,2)有可靠的公共可用的
结果数据; 3)与当前RADx-UP站点重叠,以利用CDCC强大的基础设施
并通过测试项目支持社区参与。评估是否在家中频繁快速
检测策略在5周内减少了SARS-CoV-2的社区传播和发病率,
我们的主要结果包括社区传播的测量(医院容量/卫生保健利用,
社区传播、废水监测的综合指标)和发病率(住院,
类Covid疾病)。我们的次要结局包括(社区流动性、PCR周转时间、ICU
入院、接触者追踪事件和测试阳性百分比)。此外,我们还将进行一项子研究,
评估测试的行为决定因素(社会互动,健康行为,医疗保健利用,
预防知识和疫苗态度)使用智能手机应用程序与同意的参与者,
公共卫生干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Cohen-Wolkowiez其他文献
Michael Cohen-Wolkowiez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Cohen-Wolkowiez', 18)}}的其他基金
RADx-UP SAY YES COVID Test Study (S4)
RADx-UP 说“是”新冠病毒测试研究 (S4)
- 批准号:
10472985 - 财政年份:2020
- 资助金额:
$ 765.38万 - 项目类别:
Mentoring in Clinical Pharmacology and Early Phase Trials
临床药理学和早期试验的指导
- 批准号:
10394817 - 财政年份:2019
- 资助金额:
$ 765.38万 - 项目类别:
Mentoring in Clinical Pharmacology and Early Phase Trials
临床药理学和早期试验的指导
- 批准号:
10620632 - 财政年份:2019
- 资助金额:
$ 765.38万 - 项目类别:
Physiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children
基于生理学的儿童最佳药物剂量的药代动力学模型
- 批准号:
8661919 - 财政年份:2014
- 资助金额:
$ 765.38万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 765.38万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 765.38万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 765.38万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 765.38万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 765.38万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 765.38万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 765.38万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 765.38万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 765.38万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 765.38万 - 项目类别:
Research Grant